Effects of Exendin-4 on bone marrow mesenchymal stem cell proliferation, migration and apoptosis in vitro

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhou, Hao ^a   Li, Dandan ^a   Shi, Chen ^b   Xin, Ting ^c   Yang, Junjie ^a   Zhou, Ying ^a   Hu, Shunyin ^a   Tian, Feng ^a   Wang, Jing ^a   Chen, Yundai ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, RAT; EXENDIN 4; HYDROGEN PEROXIDE; PEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; VENOM;

ANIMAL; APOPTOSIS; BONE MARROW CELL; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECTS; MESENCHYMAL STROMA CELL; METABOLISM; MITOCHONDRION; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; HYDROGEN PEROXIDE; MESENCHYMAL STROMAL CELLS; MITOCHONDRIA; PEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; VENOMS;

EID: 84938868077     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12898     Document Type: Article

References (64)

1. Russo, V., Young, S., Hamilton, A., Amsden, B. G. & Flynn, L. E. Mesenchymal stem cell delivery strategies to promote cardiac regeneration following ischemic injury. Biomaterials 35, 3956-3974; doi: 10.1016/j.biomaterials.2014.01.075 (2014).
2. Flynn, A. & O'Brien, T. Stem cell therapy for cardiac disease. Expert Opin Biol Ther 11, 177-187; doi: 10.1517/14712598.2011.543894 (2011).
3. Jeevanantham, V., Afzal, M. R., Zuba-Surma, E. K. & Dawn, B. Clinical trials of cardiac repair with adult bone marrow- derived cells. Methods Mol Biol 1036, 179-205; doi: 10.1007/978-1-62703-511-8-15 (2013).
4. Rodrigo, S. F. et al. Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up. J Cardiovasc Transl Res 6, 816-825; doi: 10.1007/s12265-013-9507-7 (2013).
5. Wagner, W. et al. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 4, e5846; doi: 10.1371/journal.pone.0005846 (2009).
6. Bentivegna, A. et al. DNA Methylation Changes during in vitro Propagation of Human Mesenchymal Stem Cells: Implications for Their Genomic Stability? Stem Cells Int 2013, 192425; doi: 10.1155/2013/192425 (2013).
7. Potier, E. et al. Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. Tissue Eng 13, 1325-1331; doi: 10.1089/ten.2006.0325 (2007).
8. Chavakis, E. & Dimmeler, S. Homing of progenitor cells to ischemic tissues. Antioxid Redox Signal 15, 967-980; doi: 10.1089/ ars.2010.3582 (2011).
9. Dow, J., Simkhovich, B. Z., Kedes, L. & Kloner, R. A. Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. Cardiovasc Res 67, 301-307; doi: 10.1016/j.cardiores.2005.04.011 (2005).
10. Li, Y. et al. Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Commun 356, 780-784; doi: 10.1016/j.bbrc.2007.03.049 (2007).
11. Wang, W. X. et al. Nerve growth factor induces cord formation of mesenchymal stem cell by promoting proliferation and activating the PI3K/Akt signaling pathway. Acta Pharmacol Sin 32, 1483-1490; doi: 10.1038/aps.2011.141 (2011).
12. Xu, J. et al. High density lipoprotein protects mesenchymal stem cells from oxidative stress-induced apoptosis via activation of the PI3K/Akt pathway and suppression of reactive oxygen species. Int J Mol Sci 13, 17104-17120; doi: 10.3390/ijms131217104 (2012).
13. Zhao, Y. et al. rhPDGF-BB promotes proliferation and osteogenic differentiation of bone marrow stromal cells from streptozotocininduced diabetic rats through ERK pathway. Biomed Res Int 2014, 637415; doi: 10.1155/2014/637415 (2014).
14. Xu, J. et al. High density lipoprotein cholesterol promotes the proliferation of bone-derived mesenchymal stem cells via binding scavenger receptor-B type I and activation of PI3K/Akt, MAPK/ERK1/2 pathways. Mol Cell Biochem 371, 55-64; doi: 10.1007/ s11010-012-1422-8 (2012).
15. Wang, J. et al. CX43 change in LPS preconditioning against apoptosis of mesenchymal stem cells induced by hypoxia and serum deprivation is associated with ERK signaling pathway. Mol Cell Biochem 380, 267-275; doi: 10.1007/s11010-013-1683-x (2013).
16. Tahrani, A. A., Bailey, C. J., Del Prato, S. & Barnett, A. H. Management of type 2 diabetes: new and future developments in treatment. Lancet 378, 182-197; doi: 10.1016/S0140-6736(11)60207-9 (2011).
17. Li, Y. et al. beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1. Diabetes 54, 482-491 (2005).
18. Chang, G. et al. Cardioprotective effects of exenatide against oxidative stress-induced injury. Int J Mol Med 32, 1011-1020; doi: 10.3892/ijmm.2013.1475 (2013).
19. Ban, K. et al. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagonlike peptide 1 receptor-dependent and -independent pathways. Circulation 117, 2340-2350; doi: 10.1161/CIRCULATIONAHA. 107.739938 (2008).
20. Anagnostis, P. et al. Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control. Diabetes Obes Metab 13, 302-312; doi: 10.1111/j.1463-1326.2010.01345.x (2011).
21. Favaro, E. et al. The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/ protein kinase A (PKA) signalling pathways. Diabetologia 55, 1058-1070; doi: 10.1007/s00125-011-2423-y (2012).
22. Sun, X., Gao, X., Zhou, L., Sun, L. & Lu, C. PDGF-BB-induced MT1-MMP expression regulates proliferation and invasion of mesenchymal stem cells in 3-dimensional collagen via MEK/ERK1/2 and PI3K/AKT signaling. Cell Signal 25, 1279-1287; doi: 10.1016/j.cellsig.2013.01.029 (2013).
23. Morgan, D. O. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 13, 261-291; doi: 10.1146/annurev.cellbio.13.1.261 (1997).
24. Ishida, S. et al. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol 21, 4684-4699; doi: 10.1128/MCB.21.14.4684-4699.2001 (2001).
25. Liu, X. et al. SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein Cell 2, 845-854; doi: 10.1007/s13238-011-1097-z (2011).
26. Liu, J. et al. The stem cell adjuvant with Exendin-4 repairs the heart after myocardial infarction via STAT3 activation. J Cell Mol Med 18, 1381-1391; doi: 10.1111/jcmm.12272 (2014).
27. Regula, K. M. & Kirshenbaum, L. A. Apoptosis of ventricular myocytes: a means to an end. J Mol Cell Cardiol 38, 3-13; doi: 10.1016/j.yjmcc.2004.11.003 (2005).
28. Li, Y., Shelat, H. & Geng, Y. J. IGF-1 prevents oxidative stress induced-apoptosis in induced pluripotent stem cells which is mediated by microRNA-1. Biochem Biophys Res Commun 426, 615-619; doi: 10.1016/j.bbrc.2012.08.139 (2012).
29. Wei, H., Li, Z., Hu, S., Chen, X. & Cong, X. Apoptosis of mesenchymal stem cells induced by hydrogen peroxide concerns both endoplasmic reticulum stress and mitochondrial death pathway through regulation of caspases, p38 and JNK. J Cell Biochem 111, 967-978; doi: 10.1002/jcb.22785 (2010).
30. Zhou, H. et al. Exendin-4 protects adipose-derived mesenchymal stem cells from apoptosis induced by hydrogen peroxide through the PI3K/Akt-Sfrp2 pathways. Free Radic Biol Med 77, 363-375; doi: 10.1016/j.freeradbiomed.2014.09.033 (2014).
31. Li, W. et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25, 2118-2127; doi: 10.1634/ stemcells.2006-0771 (2007).
32. Nishikawa, S. et al. Nicorandil regulates Bcl-2 family proteins and protects cardiac myocytes against hypoxia-induced apoptosis. J Mol Cell Cardiol 40, 510-519; doi: 10.1016/j.yjmcc.2006.01.020 (2006).
33. Templin, C., Luscher, T. F. & Landmesser, U. Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments. Int J Dev Biol 55, 407-417; doi: 10.1387/ ijdb.103219ct (2011).
34. Strauer, B. E. & Steinhoff, G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol 58, 1095-1104; doi: 10.1016/j.jacc.2011.06.016 (2011).
35. Krane, M., Wernet, O. & Wu, S. M. Promises and pitfalls in cell replacement therapy for heart failure. Drug Discov Today Dis Mech 7, e109-e115; doi: 10.1016/j.ddmec.2010.07.004 (2010).
36. Przybyt, E. & Harmsen, M. C. Mesenchymal stem cells: promising for myocardial regeneration? Curr Stem Cell Res Ther 8, 270-277 (2013).
37. Chavakis, E., Urbich, C. & Dimmeler, S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol 45, 514-522; doi: 10.1016/j.yjmcc.2008.01.004 (2008).
38. Kan, I., Melamed, E. & Offen, D. Integral therapeutic potential of bone marrow mesenchymal stem cells. Curr Drug Targets 6, 31-41 (2005).
39. Wang, J. A. et al. Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacol Sin 29, 74-82; doi: 10.1111/j.1745-7254.2008.00716.x (2008).
40. Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J. & Kessler, P. D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93-98 (2002).
41. Shi, R. Z. & Li, Q. P. Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease. Biochem Biophys Res Commun 376, 247-250; doi: 10.1016/j.bbrc.2008.09.004 (2008).
42. Izadpanah, R. et al. Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res 68, 4229-4238; doi: 10.1158/0008-5472.CAN-07-5272 (2008).
43. Drucker, D. J. & Nauck, M. A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368, 1696-1705; doi: 10.1016/S0140-6736(06)69705-5 (2006).
44. Zhu, Z. Q., Wang, D., Xiang, D., Yuan, Y. X. & Wang, Y. Calcium/calmodulin-dependent serine protein kinase is involved in exendin-4-induced insulin secretion in INS-1 cells. Metabolism 63, 120-126; doi: 10.1016/j.metabol.2013.09.009 (2014).
45. Hillyer, P., Mordelet, E., Flynn, G. & Male, D. Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. Clin Exp Immunol 134, 431-441 (2003).
46. Alsayed, Y. et al. Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood 109, 2708-2717; doi: 10.1182/blood-2006-07-035857 (2007).
47. Son, B. R. et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24, 1254-1264; doi: 10.1634/stemcells.2005-0271 (2006).
48. Honczarenko, M. et al. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24, 1030-1041; doi: 10.1634/stemcells.2005-0319 (2006).
49. Lu, H. H., Li, Y. F., Sheng, Z. Q. & Wang, Y. Preconditioning of stem cells for the treatment of myocardial infarction. Chin Med J (Engl) 125, 378-384 (2012).
50. Jaeschke, H. & Mitchell, J. R. Mitochondria and xanthine oxidase both generate reactive oxygen species in isolated perfused rat liver after hypoxic injury. Biochem Biophys Res Commun 160, 140-147 (1989).
51. Kilbride, S. M. & Prehn, J. H. Central roles of apoptotic proteins in mitochondrial function. Oncogene 32, 2703-2711; doi: 10.1038/onc.2012.348 (2013).
52. Deveraux, Q. L. et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17, 2215-2223; doi: 10.1093/emboj/17.8.2215 (1998).
53. Li, P. et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489 (1997).
54. Olson, M. & Kornbluth, S. Mitochondria in apoptosis and human disease. Curr Mol Med 1, 91-122 (2001).
55. Liu, J. et al. Exendin-4 pretreated adipose derived stem cells are resistant to oxidative stress and improve cardiac performance via enhanced adhesion in the infarcted heart. PLoS One 9, e99756; doi: 10.1371/journal.pone.0099756 (2014).
56. Mirotsou, M. et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci USA 104, 1643-1648; doi: 10.1073/pnas.0610024104 (2007).
57. Alfaro, M. P. et al. sFRP2 suppression of bone morphogenic protein (BMP) and Wnt signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair. J Biol Chem 285, 35645-35653; doi: 10.1074/jbc.M110.135335 (2010).
58. Gehmert, S., Sadat, S., Song, Y. H., Yan, Y. & Alt, E. The anti-apoptotic effect of IGF-1 on tissue resident stem cells is mediated via PI3-kinase dependent secreted frizzled related protein 2 (Sfrp2) release. Biochem Biophys Res Commun 371, 752-755; doi: 10.1016/j.bbrc.2008.04.151 (2008).
59. Liu, H. et al. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha in MSCs. Biochem Biophys Res Commun 401, 509-515; doi: 10.1016/j.bbrc.2010.09.076 (2010).
60. Bulj, Z. et al. Protein kinase B/AKT isoform 2 drives migration of human mesenchymal stem cells. Int J Oncol 42, 118-126; doi: 10.3892/ijo.2012.1700 (2013).
61. Woo, J. S. et al. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. Arterioscler Thromb Vasc Biol 33, 2252-2260; doi: 10.1161/ATVBAHA.113.301586 (2013).
62. Lonborg, J. et al. Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with ST-segment elevation myocardial infarction. Am Heart J 164, 538-546; doi: 10.1016/j.ahj.2012.07.021 (2012).
63. Scholte, M. et al. Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial. Trials 12, 240; doi: 10.1186/1745-6215-12-240 (2011).
64. Lonborg, J. et al. Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and shortduration of ischemia. Circ Cardiovasc Interv 5, 288-295; doi: 10.1161/CIRCINTERVENTIONS.112.968388 (2012).